
Indian researchers have developed an mRNA vaccine candidate against the dengue virus capable of neutralizing all four pathogen strains. They analyzed gene sequences collected over six decades to develop the vaccine candidate. The mRNA vaccine candidate is being readied for clinical trials as an alternative to existing dengue vaccines, which use live attenuated versions of the dengue virus across the four serotypes. This vaccine works by 'teaching' cells how to make copies of viral protein so the body can recognize and fight off future infections with similar viruses.
Like
Save
Share